Latest Pharmaceutical manufacturing News
Speedier drug approvals hit slowdown as FDA faces scrutiny
WASHINGTON (AP) — Expedited drug approvals slowed this year as the Food and Drug Administration's controversial accelerated pathway came under new scrutiny from Congress, government watchdogs and some of the agency’s own leaders. With less than a month remaining in the year, the...
Pfizer announces $750M expansion of western Michigan plant
LANSING, Mich. (AP) — Pfizer announced a $750 million project Monday toward expanding capacity at the western Michigan pharmaceutical plant where the company first mass produced its COVID-19 vaccine. Company officials said the project will boost the plant’s manufacturing of...
FDA clears 1st fecal transplant treatment for gut infection
WASHINGTON (AP) — U.S. officials have approved the first pharmaceutical-grade version of the so-called fecal transplant procedures that doctors have increasingly used against hard-to-treat intestinal infections. The Food and Drug Administration on Wednesday approved Rebyota for...
Moderna, Biogen rise; Oatly, Dentsply fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday: Monday.com Ltd., up $6.91 to $102.10. The project management software developer reported strong third-quarter financial results. Moderna Inc., up $7.83 to $179.03. ...
New Zealand targets cow burps to help reduce global warming
PALMERSTON NORTH, New Zealand (AP) — How do you stop a cow from burping? It might sound like the start of a humorous riddle, but it's the subject of a huge scientific inquiry in New Zealand. And the answer could have profound effects on the health of the planet. ...
Twitter Blue signups unavailable after raft of fake accounts
Twitter's relaunched premium service — which grants blue-check “verification” labels to anyone willing to pay $8 a month — was unavailable Friday after the social media platform was flooded by a wave of imposter accounts it itself had approved. It's the latest...
Biogen tabs veteran pharma leader Viehbacher as next CEO
Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the Alzheimer’s treatment Aduhelm. The company said Thursday that the 62-year-old Viehbacher will become president and CEO on...
New Hampshire Democrats Pappas, Kuster reelected to Congress
CONCORD, N.H. (AP) — Democrats Annie Kuster and Chris Pappas both won reelection to Congress in New Hampshire’s 1st and 2nd Districts, defeating two pro-Trump Republicans. Pappas defeated Karoline Leavitt, who worked in the White House press office under former President Donald...
Democrat Ron Wyden wins reelection to US Senate from Oregon
PORTLAND, Ore. (AP) — Oregon’s senior U.S. senator, Democrat Ron Wyden, won reelection easily Tuesday, defeating a Republican opponent who has never held elected office. Wyden, who was first elected to the Senate in 1996, chairs the powerful U.S. Senate Finance Committee and...
BioNTech earnings drop but forecast for vaccine income grows
BERLIN (AP) — BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, reported that its earnings in the third quarter were close to half what they were a year earlier, but the German pharmaceutical company still raised its expectations for vaccine revenue after rolling out...
